In 2014 WHO issued new policy guidance for the use of Xpert MTB/RIF in the diagnosis of TB among people with suspected EPTB.
The WHO recommends
that Xpert MTB/RIF should be used as the initial diagnostic test in testing cerebrospinal fluid specimens from patients presumed to have TB meningitis.
Though the data is limited, published studies indicate that Xpert MTB/RIF has low sensitivity for pleural TB.